Viracta Therapeutics Inc (NASDAQ:VIRX) currently has a daily average trading volume of 1.25M but it saw 43674751 shares traded in last market. With a market cap of 7.24M USD, the company’s current market price of $0.18 came rising about 11.98 while comparing to the previous closing price of $0.16. In past 52 weeks, the stock remained buoying in the range of price level as high as $1.31 and as low as $0.13. In the recent trading on the day, stock has struck highest price mark of $0.1606 while lowest mark touched by it was $0.2035.
Taking a look at 20-day trading activity of Viracta Therapeutics Inc (VIRX) gives us an average price of $0.1619, while its current price level is -86.08% below from 52-week high level whereas it is 38.63% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.2002 while that of 200 days or SMA-200 reads an average of $0.5356. A closer look into the stock’s movement over the week reveals that its volatility is standing at 15.79% during that period while stretching the period over a month that decreases to 11.18%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 53.83 which implies that the stock is in neutral territory.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Leerink Partners which downgraded the stock as “Market Perform” in its note to investors issued on August 16, 2024, recommending a price target of between $5 and $3 for it. H.C. Wainwright issued its recommendations for the stock as it initiated the price target for the stock is $35.
Over the week, VIRX’s stock price is moving 27.84% up while it is -8.85% when we observe its performance for the past one month. Year-to-date it is -68.02% down and over the past year, the stock is showing a downside performance of -60.86%.
Currently, Viracta Therapeutics Inc’s total number of outstanding shares is 39.74M. Company’s return on equity (ROE) at -370.13%. Stock’s beta reads 0.68. Its return on asset (ROA) is -97.94% on average.
